Unblinded: A Clinical Trial Podcast – Details, episodes & analysis

This week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development.

Already well-known in our industry for his pioneering research on protocol design complexity and trial efficiency, Ken’s most recent study found that the average number of amendments per protocol increased by almost 60% over the past seven years.

In this episode, Richard and Ken debate whether clinical research is striking the right balance in its approach to risk and innovation, the problem-solving role played by sites, and CISCRP’s work to improve public trust in scientific advances.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

In this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect novel insights from large volumes of data. But has this influx of data and tech caused us to move farther away from the patients we serve?

Together Terttu, Leonie, and Richard outline the major opportunities for life sciences organizations to put patients back at the heart of clinical strategy.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Rhona O’Donnell, VP, Data Management Systems and Standards, Novo Nordisk

This week, Richard Young is joined by Rhona O’Donnell, VP, Data Management Systems and Standards at Novo Nordisk. They discuss the evolution of the data management role, and how we can prepare for the future through collaboration and more effective training for the next generation. Richard and Rhona share their thoughts on the growing list of responsibilities facing data managers; why risk-based data management can help make trials more sustainable; the largest opportunities for time savings within the data management world; and the big initiatives that Novo Nordisk is working on to improve their data management processes. 

Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com

Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

This week, Richard Young speaks to Alan Morgan, CEO Advisor of Excelya. In recent years, sponsors and CROs have invested heavily in “big data” tools for site selection and productivity. But, has that investment paid off? Richard and Alan discuss whether we’ve come any closer to truly patient-centric trials – and what we still have left to do. From partnering with patient advocacy groups to going back to the basics on data management, this episode covers some new industry initiatives that could make a positive difference for patients.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Luis E. Torres, Head of Clinical Programming FSPx, Labcorp

This week, Richard Young speaks to Luis E. Torres, head of Clinical Programming FSPx at LabCorp. They discuss how data managers can prepare for the future of clinical trials by adopting new technologies and skills to keep decentralized clinical teams connected. Richard and Luis share their thoughts on designing studies and processes that support end-user needs; the shifting goal posts of data cleanliness and database build expectations; and why data managers are uniquely positioned to solve the “Rubik’s Cube” of challenges involving people, processes, and technology.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Mayank Anand, VP and Global Head of Data Strategy and Management, GSK

In this week’s conversation, Richard Young and Mayank Anand, global head of data strategy and management at GSK and Chair of SCDM, discuss how clinical data professionals’ roles are evolving in a world of decentralized data. It’s a great time to be a clinical data professional, they agree, as a once invisible role moves front and center to optimize trial protocols, operations, and results, and speed patient access to better treatments. SCDM offers professionals a global voice and a forum for discussion and debate, and Mayank summarizes the organization’s key goals. Both Richard and Mayank share insights into understanding end user and patient needs; balancing the needs of different stakeholders; and solving a Rubik’s cube of challenges that involve people, processes, and technology. Mayank also shows how new perspectives are driving a more inclusive strategy and collaborative mindset that is already improving patient focus and business results at GSK and within the industry.

Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Natalie Townsend, VP, Strategy, Veeva RTSM

This week, Richard Young speaks to Natalie Townsend, the global lead for Randomization and Trial Supply Management (RTSM) strategy at Veeva. They discuss the evolution of ‘digital’ clinical trials from the early days of phone-based and spreadsheet-centered activities to the role technology is playing today. Will data management clash, combine, or sit comfortably with the world of site supplies and randomization? And how can technology help with challenges faced by both sides?

Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, Vice President, Vault CDMS Strategy, Veeva

Guest: Trevor Griffiths, Senior Director, Clinical Data Management, Syneos Health

Description: Host Richard Young speaks to Trevor Griffiths, senior director for clinical data management at Syneos Health. Data management is becoming much more complex for CROs, as trials become larger and data sources more diverse. Yet Syneos was still able to eliminate 3,000 hours of manual review in a single trial through machine learning. As the industry moves to a single view of all clinical study data, will we get clean data ready faster? What does this mean for the role of the data manager? *Veeva CDB refers to Veeva’s clinical data platform for complete and concurrent data (available late 2022).

Subscribe to State of Digital Clinical Trials, a Veeva podcast, on Apple or Spotify to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, Vice President, Vault CDMS Strategy, Veeva

Guest: Doug Bain, Chief Technology Officer, KCR

Host Richard Young speaks to Doug Bain, chief technology officer at KCR, a contract research organization (CRO). They discuss the role of electronic data capture (EDC) in today’s complex, dynamic clinical trial landscape. With only a fraction of trial data coming from EDC, are its days numbered? And what are some of the tangible opportunities made possible by digital clinical trials that could ease the burden on sites and patients?

Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, on Apple (https://go.veeva.com/podcast-digital-...),Spotify (https://go.veeva.com/veeva-digital-tr...), and Youtube ( ) to get new episodes as soon as they are released.

Host: Richard Young, Vice President, Vault CDMS Strategy, Veeva Systems

Guest: Tanya du Plessis (Chief Data Strategist and Solutions Officer, Bioforum the Data Masters)

Description: Host Richard Young speaks to Tanya du Plessis, chief data strategist and solutions officer at Bioforum the Data Masters, a data-focused CRO. The old days of linear trial processes and pushing paper are thankfully over, presenting exciting opportunities in clinical data management. In fact, data managers are moving from behind the scenes to center stage as regulations change. So what do data managers need in their toolkit if they are to be effective? And are we closer to making patient-centric trials a reality?